Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001178711-13-000038
Filing Date
2013-08-08
Accepted
2013-08-08 16:15:14
Documents
10
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tspt-0630201310q.htm 10-Q 825417
2 EXHIBIT 31.1 tspt-06302013exh311.htm EX-31.1 9034
3 EXHIBIT 31.2 tspt-06302013exh312.htm EX-31.2 8909
4 EXHIBIT 32.1 tspt-06302013exh321.htm EX-32.1 8529
  Complete submission text file 0001178711-13-000038.txt   5696031

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT tspt-20130630.xml EX-101.INS 645216
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tspt-20130630.xsd EX-101.SCH 22130
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tspt-20130630_cal.xml EX-101.CAL 37059
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tspt-20130630_def.xml EX-101.DEF 120951
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tspt-20130630_lab.xml EX-101.LAB 288103
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tspt-20130630_pre.xml EX-101.PRE 161728
Mailing Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804
Business Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804 (510) 215-3500
Transcept Pharmaceuticals Inc (Filer) CIK: 0001178711 (see all company filings)

EIN.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51967 | Film No.: 131022368
SIC: 2834 Pharmaceutical Preparations